JAMIE BAYLOR: Open Payments
NPI 1245015445 · RENTON, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$554 in 27 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $80 · 2025 $554
Food & beverage: $484Education: $70
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $166 |
| GENZYME CORPORATION | 10 | $154 |
| SANOFI-AVENTIS U.S. LLC | 1 | $70 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Organon LLC | 1 | $8 |
Products named: DUPIXENT, AIRSUPRA, NUCALA, EOHILIA, TEZSPIRE, Rhapsido, FASENRA, BREZTRI.
Industry payments across WA — which companies pay providers there.
